Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
TFF Pharmaceuticals
(NASDAQ:TFFP)
Intraday
$3.9801
0.8901
[28.81%]
After-Hours
$3.9801
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$3.9801
0.8901
[28.81%]
At close: Apr 15
$3.9801
0
[0.00%]
After Hours: 9:09AM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for TFF Pharmaceuticals Stock (NASDAQ:TFFP)
TFF Pharmaceuticals Stock (NASDAQ: TFFP)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, April 15, 2024
TFF Pharmaceuticals Announces Additional Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions
Benzinga Newsdesk
-
Apr 15, 2024, 7:11AM
Thursday, March 28, 2024
TFF Pharmaceuticals Q4 EPS $(2.01) Beats $(2.12) Estimate, Sales $114.33K Beat $100.00K Estimate
Benzinga Newsdesk
-
Mar 28, 2024, 4:20PM
Roth MKM Maintains Buy on TFF Pharmaceuticals, Lowers Price Target to $44
Benzinga Newsdesk
-
Mar 28, 2024, 1:01PM
Wednesday, March 27, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Mar 27, 2024, 4:31PM
TFF Pharmaceuticals Announces Updated Data From Tacrolimus Inhalation Powder Voriconazole Inhalation Powder Clinical Programs; Says Eight Of Eight Patients Successfully Transitioned From Oral Tacrolimus To TFF TAC With No Sign Of Acute Rejection At Reduced Systemic Exposures
Benzinga Newsdesk
-
Mar 27, 2024, 4:05PM
Monday, March 25, 2024
TFF Pharmaceuticals Announces Oral Presentation Of Interim Data From The Phase 2 Study Of Tacrolimus Inhalation Powder For The Prevention Of Lung Transplant Rejection At The 44th Annual ISHLT 2024 Meeting
Benzinga Newsdesk
-
Mar 25, 2024, 9:16AM
Wednesday, March 20, 2024
TFF Pharmaceuticals Announces $1.2M Registered Direct Offering Of 147,500 Shares At $8.00/Share
Benzinga Newsdesk
-
Mar 20, 2024, 12:02PM
TFF Pharmaceuticals Announces Clinical Programs Update And Strategic Prioritization; Company To Prioritize TFF TAC Program Based On Phase 2 Data
Benzinga Newsdesk
-
Mar 20, 2024, 9:10AM
Wednesday, January 24, 2024
TFF Pharmaceuticals To Present Data From Phase 2 Trial Of Voriconazole Inhalation Powder For Treatment Of Invasive Pulmonary Aspergillosis At 11th Advances Against Aspergillosis & Mucormycosis Conference
Benzinga Newsdesk
-
Jan 24, 2024, 8:17AM
Tuesday, January 09, 2024
TFF Pharmaceuticals Announces Acceptance Of Late-Breaking Abstract For Presentation At The 44th Annual International Society For Heart And Lung Transplantation 2024 Meeting
Benzinga Newsdesk
-
Jan 9, 2024, 8:13AM
Tuesday, December 19, 2023
Bluebird Bio, Vertex Energy And Other Big Stocks Moving Lower On Tuesday
Avi Kapoor
-
Dec 19, 2023, 10:19AM
TFF Pharmaceuticals Announced Initial Data From Its Ongoing Phase 2 Trials Of TFF VORI And TFF TAC, Along With Clinical Data From The Ongoing TFF VORI Expanded Access Program
Benzinga Newsdesk
-
Dec 19, 2023, 6:05AM
Monday, December 18, 2023
TFF Pharmaceuticals To Hold Conference Call And Webcast To Review Initial Data From Ongoing Phase 2 Trials Of TFF VORI And TFF TAC On Dec. 19 At 8:30 a.m. ET
Bill Haddad
-
Dec 18, 2023, 4:04PM
Friday, December 15, 2023
TFF Pharmaceuticals Announces Reverse Stock Split At A Ratio Of 1 Post-Split Share For Every 25 Pre-Split Shares
Benzinga Newsdesk
-
Dec 15, 2023, 7:04AM
Tuesday, November 14, 2023
TFF Pharmaceuticals Q3 EPS $(0.09) Beats $(0.11) Estimate, Sales $234.76K Beat $50.00K Estimate
Benzinga Newsdesk
-
Nov 14, 2023, 4:52PM
Earnings Scheduled For November 14, 2023
Benzinga Insights
-
Nov 14, 2023, 8:23AM
Monday, November 13, 2023
Preview: TFF Pharmaceuticals's Earnings
Benzinga Insights
-
Nov 13, 2023, 11:01AM
Wednesday, November 08, 2023
TFF Pharmaceuticals Announces Publication Of Data Demonstrating Feasibility Of Intranasal Delivery Of Monoclonal Antibodies With Thin Film Freezing
Benzinga Newsdesk
-
Nov 8, 2023, 5:18PM
Monday, August 28, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Aug 28, 2023, 5:31PM
Friday, August 18, 2023
10% Owner At This Health Care Company Sells $94K of Stock
Benzinga Insights
-
Aug 18, 2023, 11:02AM
Tuesday, August 15, 2023
Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Aug 15, 2023, 2:01PM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Aug 15, 2023, 9:06AM
Why Delcath Systems Shares Are Trading Higher By Around 58%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Aug 15, 2023, 8:17AM
TFF Pharmaceuticals Has Priced Its Underwritten Public Offering Of 19.8M At $0.25/Share, Gross Proceeds Of Approximately $4.97M
Benzinga Newsdesk
-
Aug 15, 2023, 6:31AM
TFF Pharmaceuticals Q2 EPS $(0.14) Beats $(0.19) Estimate, Sales $333.35K Beat $70.00K Estimate, Cash Balance of $7.7M Expected to Extend Cash Runway through Q1 of 2024
Benzinga Newsdesk
-
Aug 15, 2023, 6:11AM
Monday, August 14, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Aug 14, 2023, 5:32PM
TFF Pharmaceuticals Announces Proposed Public Offering Of Common Stock; No Size Or Amount Disclosed
Benzinga Newsdesk
-
Aug 14, 2023, 4:44PM
Earnings Scheduled For August 14, 2023
Benzinga Insights
-
Aug 14, 2023, 6:45AM
Monday, July 31, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Jul 31, 2023, 5:31PM
TFF Pharmaceuticals, Uniphar Durbin Ireland Open Expanded Access Program for Voriconazole Inhalation Powder For Pulmonary Aspergillosis And Other Voriconazole Responsive Fungal Pulmonary Infections
Benzinga Newsdesk
-
Jul 31, 2023, 7:10AM
Thursday, July 20, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Jul 20, 2023, 5:32PM
Wednesday, June 07, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Jun 7, 2023, 12:38PM
Thursday, May 25, 2023
HC Wainwright & Co. Maintains Buy Rating for TFF Pharmaceuticals: Here's What You Need To Know
Benzinga Insights
-
May 25, 2023, 1:00PM
HC Wainwright & Co. Maintains Buy on TFF Pharmaceuticals, Lowers Price Target to $4
Benzinga Newsdesk
-
May 25, 2023, 6:11AM
Thursday, May 04, 2023
TFF Pharmaceuticals Enters Into CRADA With The National Institute Of Environmental Health Sciences To Develop Dry Powder Formulations Of Hyaluronan To Prevent And Treat Respiratory Diseases
Happy Mohamed
-
May 4, 2023, 8:21AM
Monday, May 01, 2023
TFF Pharmaceuticals Secures Additional Funding From Leidos To Advance Next-Generation Personalized Protective Biosystems Under DARPA PPB Program
Benzinga Newsdesk
-
May 1, 2023, 7:09AM
Wednesday, April 26, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Apr 26, 2023, 2:37PM
Wednesday, March 22, 2023
Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2023
Benzinga Insights
-
Mar 22, 2023, 11:00AM
JonesTrading Initiates Coverage On TFF Pharmaceuticals with Buy Rating, Announces Price Target of $7
Benzinga Newsdesk
-
Mar 22, 2023, 5:07AM
Friday, March 17, 2023
HC Wainwright & Co. Reiterates Buy on TFF Pharmaceuticals, Maintains $22 Price Target
Benzinga Newsdesk
-
Mar 17, 2023, 6:30AM
Tuesday, March 14, 2023
TFF Pharmaceuticals And 3 Other Stocks Under $5 Insiders Are Aggressively Buying
Lisa Levin
-
Mar 14, 2023, 8:37AM
Monday, March 13, 2023
131K Reasons To Be Bullish On TFF Pharmaceuticals Stock
Benzinga Insights
-
Mar 13, 2023, 11:00AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Mar 13, 2023, 9:06AM
Wednesday, March 08, 2023
TFF Pharmaceuticals Says On March 2, 2023 Co. Received Notice Of Delisting From Nasdaq Stock Market
Michael Horton
-
Mar 8, 2023, 4:40PM
Tuesday, February 21, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Feb 21, 2023, 12:37PM
Monday, February 20, 2023
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Feb 20, 2023, 12:31PM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Feb 20, 2023, 8:05AM
Friday, February 17, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Feb 17, 2023, 12:30PM
Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Feb 17, 2023, 12:26PM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Feb 17, 2023, 8:06AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch